Background: Bronchopulmonary dysplasia (BPD) is a common neonatal lung disease that is underpinned by pulmonary inflammation. Despite extensive research, a dominant immune pathway that drives BPD remains elusive.
Methods: Cord and peripheral blood was collected from: i) infants born at 24-29 gestational weeks at birth, on days 1, 7 and 14, and at 36 weeks gestational age; ii) healthy term infants at birth and at 4-16 weeks of age; iii) healthy adults. Following overnight stimulation with PMA+ionomycin or vehicle, the Th1/2/17 and regulatory T cell (Treg) subsets were enumerated by flow cytometry. Results were analysed against BPD status and clinical events such as respiratory support, sepsis and medication.
Results: 51 preterm infants, 20 term infants and 5 adults were enrolled, and 258 unique samples collected. Th2 polarisation predominated in preterm and term infants up to 16 weeks of age, with up to 62% of CD4+ T cells Th2-polarised vs 2% in adults. Baseline Th1 and Th17-polarisation was low in all groups; inducibility of Th1 and Th17-polarisation developed at 16 weeks of age. The percentage of Treg was 5-fold higher in infants than in adults. The 36 preterm infants who suffered from BPD exhibited up to 36-fold increased frequencies of Th2-polarised T cells at most timepoints.
Conclusions: Our study sheds light on the maturation of the immune system in preterm and term infants. The severe chronic lung disease BPD is associated with strong Th2 polarisation, suggesting that therapies targeting the Th2 pathway may offer benefit to the tiny BPD patients. University, Auckland, New Zealand Background: Emerging evidence suggests that HPV is associated with negative pregnancy outcomes such as preterm birth (PTB), and pre-eclampsia. We aimed to determine if prior HPV vaccination reduced adverse pregnancy outcomes.
ASSOCIATION OF PRIOR HPV VACCINATION WITH REDUCED PRETERM BIRTH: A POPULATION BASED STUDY
Methods: A New Zealand population-based retrospective study linking first pregnancy outcome data (2008-2014 n=35,646) with prior quadrivalent HPV vaccination status.
Primary outcomes were likelihood (odds ratios, ORs) of PTB, preeclampsia, and stillbirth. Exposure groups were based on HPV vaccination. Adjusted ORs were calculated for each outcome, controlling for mother's age at delivery, ethnicity, socioeconomic status, health board region at time of delivery, and body mass index and smoking status at time of registration with maternity care provider.
Results: Mother's mean age at delivery was 19 (SD 2.1) years. Of 34,994 the pregnancies included in the final study analyses 62.3% of women were unvaccinated, 11.0% vaccinated with one or two doses and 27.7% vaccinated with three doses prior to pregnancy. PTB (OR: 0.87; CI 0.78, 0.96)) was significantly lower for women who previously received the HPV vaccine. A dose response effect was found with each successive dose received decreasing the likelihood of PTB. No associations between the vaccinated and unvaccinated groups were shown for preeclampsia or stillbirth.
Conclusions: Prior receipt of the quadrivalent HPV vaccine was associated with a significant reduction in PTB (13%); suggesting that HPV vaccination may be effective in reducing PTB. The potential global public health impact is considerable and there is urgency to undertake further research to replicate and explore these findings. Methods: Visual outcomes were compared in seven-year-old children born at <30 weeks GA or <1500 g before (Before) and after (After) a reformulation of intravenous nutrition intended to increase protein and decrease fluid intake in the first week after birth. Favourable overall visual outcome was visual acuity (VA) ≤0.3 logMar in the better eye, absence of strabismus, TNO stereoacuity ≤240 seconds of arc and refractive error -0.50 to +2.00D (not requiring optical correction). Favourable functional visual outcome was overall visual outcome not including refractive error. Data are median (interquartile range) or meanAESD. Analyses were adjusted for sex and birthweight zscore.
NEONATAL NUTRITIONAL INTAKE IN PRETERM BABIES AND VISUAL OUTCOMES AT SEVEN YEARS OF AGE
Results: Before (n=55) and After (n=73) groups had similar gestation (26(25-29) v 26(25-27) weeks) and birthweight (850 (715-1040) v 900(770-1020) g). In the first week after birth, the After group had higher protein intake (2.9AE0.4 v 2.3AE0.3 g.kg 
